Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia
Abstract: Pneumonia is an acute pulmonary infection associated with high mortality and an immense financial burden on healthcare systems.
Staphylococcus aureus is an opportunistic pathogen capable of inducing S. aureus pneumonia (SAP), with some lineages also showing multidrug resistance. Given the high level of antibiotic resistance, much research has been focused on targeting S. aureus virulence factors, including toxins and biofilm-associated proteins, in an attempt to develop effective SAP therapeutics. Despite several promising leads, many hurdles still remain for S. aureus vaccine research. Here, we review the state-of-the-art SAP therapeutics, highlight their pitfalls, and discuss alternative approaches of potential significance and future perspectives.
Download publication
Related media library items
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study
Background Clinical data characterizing invasive Escherichia coli disease (IED) are limited. We assessed the clinical presentation of IED and antimicr...
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study
Purpose Invasive Escherichia coli disease (IED) encompasses a diverse range of sterile site infections. This study evaluated the feasibility of captur...
Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization
Key Points Question What is the cumulative incidence of Staphylococcus aureus surgical site infections (SSIs) and bloodstream infections (BSIs) in Eu...